Trustees of Princeton University Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Appian
APPN
|
+$2.12M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.04M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$1.23M |
| 4 |
Star Group
SGU
|
+$596K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JBGS
JBG SMITH
JBGS
|
+$15.7M |
| 2 |
P
Everpure Inc
P
|
+$10.8M |
| 3 |
Okta
OKTA
|
+$8.84M |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$6.21M |
| 5 |
Yext
YEXT
|
+$6.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 88.64% |
| 2 | Technology | 5.61% |
| 3 | Healthcare | 3.27% |
| 4 | Energy | 0.84% |
Similar funds
Trustees of Princeton University's Q1 2018 Portfolio in Review
As of Q1 2018, Trustees of Princeton University held 9 positions worth $66.9M, down 38% from $109M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trustees of Princeton University withdrew a net $41.6M in Q1 2018, closing 3 positions and reducing 2 holdings. Its most notable exit was Everpure Inc, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 89% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Trustees of Princeton University opened a new position in Appian worth $1.76M.
- Trustees of Princeton University's largest Q1 2018 buy was Appian: 70,000 shares worth $1.76M.
- Trustees of Princeton University's biggest Q1 2018 reduction was JBG SMITH, cutting an estimated $15.7M.
- Trustees of Princeton University fully exited Everpure Inc in Q1 2018, selling an estimated $10.8M.
- Trustees of Princeton University's ten largest holdings make up 100% of its $66.9M portfolio in Q1 2018.
- Trustees of Princeton University opened 4 new positions and closed 3 in Q1 2018.
- Trustees of Princeton University's portfolio value fell 38% quarter-over-quarter to $66.9M.
Based on Trustees of Princeton University's 13F filing for Q1 2018, filed 14 May 2018.